拨开迷雾：生物治疗前的乙肝病毒筛查 - Suppr

Suppr

超能文献

Let the fog be lifted: screening for hepatitis B virus before biological therapy.

作者信息

Winthrop Kevin L, Calabrese Leonard H

出版信息

Ann Rheum Dis. 2011 Oct;70(10):1701-3. doi: 10.1136/annrheumdis-2011-200163.

DOI:10.1136/annrheumdis-2011-200163

PMID:21893581

Abstract

摘要

相似文献

Let the fog be lifted: screening for hepatitis B virus before biological therapy.拨开迷雾：生物治疗前的乙肝病毒筛查

Ann Rheum Dis. 2011 Oct;70(10):1701-3. doi: 10.1136/annrheumdis-2011-200163.

Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.HBV 核心抗体阳性的类风湿关节炎患者接受抗 TNF-α 治疗时病毒载量的动力学变化及乙型肝炎病毒再激活的风险。

Ann Rheum Dis. 2011 Oct;70(10):1719-25. doi: 10.1136/ard.2010.148783. Epub 2011 Jun 29.

Lack of hepatitis B virus reactivation after anti-tumour necrosis factor treatment in potential occult carriers with chronic inflammatory arthropathies.潜在隐匿性乙型肝炎病毒携带者慢性炎症性关节炎应用肿瘤坏死因子拮抗剂治疗后病毒无再激活。

Eur J Intern Med. 2014 Jun;25(5):482-4. doi: 10.1016/j.ejim.2013.11.014. Epub 2014 Feb 2.

Chronic viral hepatitis and TNF-alpha blockade.慢性病毒性肝炎与肿瘤坏死因子-α阻断

Rheumatology (Oxford). 2007 Aug;46(8):1381; author reply 1381-2. doi: 10.1093/rheumatology/kem082. Epub 2007 Jun 13.

Reactivation of hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs.使用生物性改善病情抗风湿药物治疗的类风湿关节炎患者中乙型肝炎病毒的再激活

Int J Rheum Dis. 2016 May;19(5):470-5. doi: 10.1111/1756-185X.12359. Epub 2014 Apr 4.

Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection.抗 TNF 治疗在患有风湿性疾病和慢性或已解决的乙型肝炎病毒感染患者中的长期安全性。

Ann Rheum Dis. 2010 Jul;69(7):1352-5. doi: 10.1136/ard.2009.127233. Epub 2010 May 14.

Commensurate incidence and outcomes of liver enzyme elevation between anti-tumor necrosis factor users with or without prior hepatitis B virus infections.抗肿瘤坏死因子治疗患者中，无论是否存在乙型肝炎病毒感染，肝酶升高的发生率和结局相当。

PLoS One. 2018 Apr 25;13(4):e0196210. doi: 10.1371/journal.pone.0196210. eCollection 2018.

Reactivation of resolved hepatitis B during rituximab therapy for rheumatoid arthritis.类风湿关节炎患者在使用利妥昔单抗治疗期间，已治愈的乙型肝炎复发。

Joint Bone Spine. 2012 Jan;79(1):100-1. doi: 10.1016/j.jbspin.2011.07.003. Epub 2011 Sep 23.

Risk of Reactivation of Hepatitis B Virus Infection in Psoriasis Patients Treated With Biologics: A Retrospective Analysis of 20 Cases From the BIOBADADERM Database.接受生物制剂治疗的银屑病患者乙肝病毒感染再激活风险：来自BIOBADADERM数据库20例病例的回顾性分析

Actas Dermosifiliogr. 2015 Jul-Aug;106(6):477-82. doi: 10.1016/j.ad.2015.01.010. Epub 2015 Mar 13.

Adalimumab-induced lethal hepatitis B virus reactivation in an HBsAg-negative patient with clinically resolved hepatitis B virus infection.在一名乙肝表面抗原阴性且临床乙肝病毒感染已缓解的患者中，阿达木单抗诱发致死性乙肝病毒再激活。

Liver Int. 2010 Sep;30(8):1241-2. doi: 10.1111/j.1478-3231.2010.02238.x. Epub 2010 Mar 22.

引用本文的文献

Prevalence and clinical characteristics of hepatitis B surface antigen-negative/hepatitis B core antibody-positive patients with detectable serum hepatitis B virus DNA.血清乙肝病毒DNA可检测到的乙肝表面抗原阴性/乙肝核心抗体阳性患者的患病率及临床特征

Ann Transl Med. 2022 Jan;10(1):25. doi: 10.21037/atm-21-6272.

Viral hepatitis screening guideline before biological drug use in rheumatic patients.风湿性疾病患者使用生物药物前的病毒性肝炎筛查指南。

Eur J Rheumatol. 2016 Mar;3(1):25-28. doi: 10.5152/eurjrheum.2015.150072. Epub 2015 Oct 28.

Reactivation of occult hepatitis B virus infection in patients with rheumatic diseases: pathogenesis, risk assessment and prevention.风湿性疾病患者隐匿性乙型肝炎病毒感染的再激活：发病机制、风险评估及预防

Rheumatol Int. 2016 May;36(5):635-41. doi: 10.1007/s00296-015-3395-x. Epub 2015 Nov 16.

Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis.托法替布治疗的类风湿关节炎患者中的结核病及其他机会性感染。

Ann Rheum Dis. 2016 Jun;75(6):1133-8. doi: 10.1136/annrheumdis-2015-207319. Epub 2015 Aug 28.

Safety of biologic and nonbiologic disease-modifying antirheumatic drug therapy in veterans with rheumatoid arthritis and hepatitis B virus infection: a retrospective cohort study.生物制剂和非生物改善病情抗风湿药物治疗类风湿性关节炎合并乙型肝炎病毒感染退伍军人的安全性：一项回顾性队列研究。

Arthritis Res Ther. 2015 May 22;17(1):136. doi: 10.1186/s13075-015-0628-z.

Treatment of rheumatic diseases and hepatitis B virus coinfection.风湿性疾病与乙型肝炎病毒合并感染的治疗。

Rheumatol Int. 2015 Mar;35(3):385-92. doi: 10.1007/s00296-014-3195-8. Epub 2014 Dec 31.

The impact of hepatitis screening on diagnosis and treatment in rheumatoid arthritis.肝炎筛查对类风湿关节炎诊断和治疗的影响。

Clin Rheumatol. 2014 Dec;33(12):1823-7. doi: 10.1007/s10067-014-2612-4. Epub 2014 Apr 13.

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions.关于阻断白介素-6（尤其是白介素-6 受体抑制）在类风湿关节炎和其他炎症性疾病中的作用的共识声明。

Ann Rheum Dis. 2013 Apr;72(4):482-92. doi: 10.1136/annrheumdis-2012-202469. Epub 2012 Nov 21.

Management of rheumatic disease with comorbid HBV or HCV infection.合并 HBV 或 HCV 感染的风湿性疾病的管理。

Nat Rev Rheumatol. 2012 May 8;8(6):348-57. doi: 10.1038/nrrheum.2012.63.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验